REVIVE (Response to the Ebola Virus Vaccine)
NCT05992480
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Ebola Virus Disease
Interventions
BIOLOGICAL:
rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)
Sponsor
Tulane University
Collaborators
[object Object]
[object Object]